ANNOUNCEMENT: NSTC Markets Taiwan's R&D Capabilities in Europe and Participates in MEDICA

- NSTC markets Taiwan's R&D capabilities in precision healthcare in Europe, enabling Taiwan to shine at MEDICA 2022, the largest event for the medical industry.

ANNOUNCEMENT: NSTC Markets Taiwan's R&D Capabilities in Europe and Participates in MEDICA

- NSTC markets Taiwan's R&D capabilities in precision healthcare in Europe, enabling Taiwan to shine at MEDICA 2022, the largest event for the medical industry

TAIPEI, Nov. 15, 2022 /PRNewswire/ -- Following the aging population and the increasing demand for healthcare quality, the world is paying more attention to the development of precision health and smart healthcare. Technology will play a crucial role in driving the healthcare industry in the future. Accordingly, this year, the National Science and Technology Council (NSTC) collaborated with Hsinchu Science Park, Central Taiwan Science Park and South Taiwan Science Park, forming a delegation team to participate in MEDICA. In addition, the council established the Taiwan Smart Health Pavilion to help academic and research start-ups, as well as 51 companies, establish channels for international investment and industrial collaboration, attracting foreign capital. In addition, the delegation team participated in the 11th edition of the MEDICA start-up competition, allowing Taiwan's cutting-edge technology products to reach major European biomedical markets.

The Taiwan Smart Health Pavilion opened on November 14, German time. Shieh Jhy-wey, Taiwan's representative in Germany, was invited to the grand opening of the pavilion to express his support for the NSTC delegation team. Other representatives included MEDICA, Fraunhofer (Europe's largest applied scientific research institution) and the Europe-Taiwan Biotechnology Association (ETBA). In her opening remarks, Director Hsu Tseng-ju (from the Department of Academy-Industry Collaboration and Science Parks Affairs of NSTC) noted that Taiwan has world-renowned health capacity and ICT industry collaboration channels. In recent years, the Taiwanese government has been actively striving for interdisciplinary integration, advancing the prosperous development of precision health technology and intelligent health care. In addition, Taiwan's outstanding achievements in epidemic prevention have attracted the world's attention. The Taiwan Smart Health Pavilion brings together the start-ups, companies and hospitals of the NSTC delegation team to participate in MEDICA, hoping that Taiwan can show the world its remarkable technology, products, its talented people and its environment, and with the aim of attracting international investment and cooperation.

The NSTC helped Taiwanese teams enter the prestigious Startup Competition, and two Taiwanese teams will compete in the final on November 15, German time. More than 550 teams from around the world entered two competitions, and only 12 teams have reached the final. These teams came from countries such as Sweden, Germany, Finland, Israel, Spain, Italy, South Korea and Taiwan. Pythia Biotech and MedFluid, the two Taiwanese teams in the finals, will compete for the championship, the furthest a Taiwanese team has ever gone. Both teams are start-ups advised by the NSTC. Pythia Biotech produces Organ-on-chip, designed to recreate an ex vivo physiological and pathological environment, while MedFluid manufactures an integrated LOC (Lab-on-a-chip) microfluidic system. The two companies are willing to introduce their products to European markets through MEDICA, Taiwan Tech Arena reports.

Although Taiwanese teams possess advanced technological research and development capabilities, they currently need recognition from European markets. NSTC won the opportunity to participate in an exclusive showcase at the Medica Connected Healthcare Forum (MCHF) on November 17. There, Taiwanese teams will be able to publish their technological achievements; participate in face-to-face interactions with international accelerators, companies, venture capital, and the academic and research sector; and explain Taiwan's policies to build a precision health environment. In addition, the council actively organizes business meetings, communicating with international companies such as 3M Group, ASKLEPIOS Group, Merck Group, and ASML. In the future, the council will foster all international marketing connections, helping Taiwan's medical teams from industries and academic and research organizations to shine in the global market and creating more opportunities for Taiwan's biomedical industry.

Contacto persona 1: Sing Lin,, 01523 6809749, Industrial Technology Research InstituteContacto persona 2: Ellie Peng,, Industrial Technology Research Institute

Photo - link

View original content: enlace

Yorum yapabilmek için üye girişi yapmanız gerekmektedir.

Üye değilseniz hemen üye olun veya giriş yapın.